July 3, 2023 Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury
June 29, 2023 NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis
June 28, 2023 A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
June 26, 2023 The presence of preoperative neurodegeneration biofluid markers in patients with postoperative delirium
June 22, 2023 Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials
June 19, 2023 Elevated Serum Tau and UCHL-1 Concentrations Within 12 Months of Injury Predict Neurobehavioral Functioning 2 or More Years Following Traumatic Brain Injury: A Longitudinal Study
May 27, 2023 Levels of Alzheimer’s disease blood biomarkers are altered after food intake-A pilot intervention study in healthy adults
May 24, 2023 Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases